Medicare Enrolled
Florida Board Action on Record
The Florida Department of Health has flagged this practitioner's license with a board action.
Verify on FL DOH →
Dr. Dina Doolin, D.O.
Family Medicine · New Smyrna Beach, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Doolin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Doolin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Doolin
Dr. Dina Doolin is a family medicine specialist in New Smyrna Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Doolin performed 3,690 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Doolin received a total of $8,010 from 48 pharmaceutical and/or device companies across 407 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Doolin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 9% volume in FL
$8,010 industry payments
Florida License Status
FL DOH · MQA1
Active license
Yes
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 8699 | Clear | March 31, 2028 | ⚠ |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗3,690
Medicare services
Top 9% in FL for family medicine
Not available
Unique patients (not deduplicated)
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,440 | $18 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
653 | $87 | $122 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
323 | $0 | $0 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
167 | $10 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
165 | $60 | $89 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
123 | $80 | $111 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
118 | $121 | $128 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
99 | $5 | $6 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
66 | $0 | $1 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
54 | $43 | $66 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
52 | $0 | $1 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
51 | $12 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $113 | $169 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
48 | $4 | $12 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
47 | $40 | $52 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
36 | $28 | $29 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
35 | $75 | $78 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
34 | $3 | $9 |
| Ear wax removal by washing This procedure involves the removal of impacted ear wax using a washing technique. |
26 | $10 | $17 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
26 | $2 | $8 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
24 | $53 | $72 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
24 | $15 | $15 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
19 | $32 | $41 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
11 | $20 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,010
Total received (2018-2024)
Avg $1,144/year across 7 years
Top 6% in FL for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
407
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,651
2023
$1,073
2022
$1,184
2021
$1,661
2020
$610
2019
$1,008
2018
$823
Payments by company (2024)
Phathom Pharmaceuticals, Inc.
$426
Novo Nordisk Inc
$306
Amgen Inc.
$249
ABBVIE INC.
$151
PFIZER INC.
$132
AstraZeneca Pharmaceuticals LP
$81
Mylan Specialty L.P.
$71
Lilly USA, LLC
$60
Abbott Laboratories
$44
Xeris Pharmaceuticals, Inc.
$23
Alnylam Pharmaceuticals Inc.
$21
Astellas Pharma US Inc
$20
CVRx, Inc.
$19
Exact Sciences Corporation
$19
Almatica Pharma LLC
$18
Dexcom, Inc.
$13
Top 3 companies account for 59.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,235
Novo Nordisk Inc
$1,128
AbbVie Inc.
$686
PFIZER INC.
$641
Lilly USA, LLC
$477
Phathom Pharmaceuticals, Inc.
$426
ABBVIE INC.
$374
Novartis Pharmaceuticals Corporation
$361
Bayer HealthCare Pharmaceuticals Inc.
$252
GlaxoSmithKline, LLC.
$191
Allergan, Inc.
$181
Allergan Inc.
$144
Stryker Corporation
$125
Abbott Laboratories
$124
Boehringer Ingelheim Pharmaceuticals, Inc.
$120
Corcept Therapeutics
$116
AstraZeneca Pharmaceuticals LP
$114
SANOFI-AVENTIS U.S. LLC
$104
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$101
Almatica Pharma LLC
$88
Teva Pharmaceuticals USA, Inc.
$75
IDORSIA PHARMACEUTICALS US INC
$71
Mylan Specialty L.P.
$71
Otsuka America Pharmaceutical, Inc.
$70
Exact Sciences Corporation
$67
Astellas Pharma US Inc
$58
Vanda Pharmaceuticals Inc.
$55
Amarin Pharma Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$50
ARBOR PHARMACEUTICALS, INC.
$44
Bayer Healthcare Pharmaceuticals Inc.
$36
Genentech USA, Inc.
$34
Biohaven Pharmaceutical Holding Company Ltd.
$33
Shire North American Group Inc
$31
BOSTON SCIENTIFIC CORPORATION
$28
AbbVie, Inc.
$25
E.R. Squibb & Sons, L.L.C.
$25
Xeris Pharmaceuticals, Inc.
$23
Hologic Sales and Service, LLC
$23
Radius Health, Inc.
$21
Alnylam Pharmaceuticals Inc.
$21
Bausch Health US, LLC
$20
CVRx, Inc.
$19
Janssen Pharmaceuticals, Inc
$16
Phadia US Inc.
$14
Dexcom, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$13
Eisai Inc.
$13
Top 3 companies account for 38.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AIRSUPRA · AJOVY · APTIMA · Aimovig · BOTOX COSMETIC · BYSTOLIC · Barostim Neo System · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · CREON · Cologuard Collection Kit · Creon · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EUCRISA · EVENITY · EVUSHELD · Edarbi · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GIVLAARI · GRALISE · HETLIOZ · ID NOW INSTRUMENT · INVOKANA · IVS - VERTEBRAL AUGMENTATION PRODUCTS · ImmunoCAP · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LOREEV XR · LYRICA · Livalo · MIGRANAL · MOTEGRITY · MOUNJARO · MYDAYIS · Motegrity · NURTEC ODT · Otezla · Otovel · Ozempic · PREMARIN · Proclaim Family of SCS IPGs · Prolia · QULIPTA · QUVIVIQ · RECORLEV · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · Superion · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XIFAXAN · Xofluza · YUPELRI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
240
County median income
$66,581
Nearest hospital to ZIP centroid (approximate)
HALIFAX HEALTH MEDICAL CENTER
18.5 mi
18.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Doolin is a clinical cardiology specialist, with above-average Medicare volume (top 9% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Doolin experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Doolin performed 1,440 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Doolin receive payments from pharmaceutical companies?
Yes. Dr. Doolin received a total of $8,010 from 48 companies across 407 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Doolin's costs compare to other family medicine physicians in New Smyrna Beach?
Dr. Doolin's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Doolin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in New Smyrna Beach
Browse family medicine physicians in New Smyrna Beach ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in FL
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in FL
Which FL family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology